Background-Elevated free fatty acid (FFA) levels are known to impair aortic elastic function. In obesity, FFA levels are elevated and aortic distensibility (AD) reduced in a pattern that predominantly affects the distal aorta. Despite this, the role of FFAs in obesity-related aortic stiffness remains unclear. Methods and Results-Using vascular MRI, we aimed to determine if (1) FFA level correlated with AD in obesity; and (2) whether elevating FFA acutely and subacutely in normal-weight subjects reproduced the distal pattern of AD change in obesity. To do this, regional AD was recorded in 35 normal-weight and 70 obese subjects and then correlated with FFA levels. When compared with normal weight, obesity was associated with reduced AD in a pattern predominantly affecting the distal aorta (ascending aorta by Ϫ22%, proximal descending aorta by Ϫ25%, and abdominal aorta by Ϫ35%; PϽ0.001). After controlling for age, blood pressure, and body mass index, FFA levels remained negatively correlated with abdominal AD (rϭϪ0.43, PϽ0.01). In 2 further normal-weight groups, AD was recorded before and after elevation of FFA levels with intralipid infusion (by ϩ535%, nϭ9) and a 5-day high-fat, low-carbohydrate diet (by ϩ48%, nϭ14).
Clinical Perspective on p 375
Obesity in the absence of hypertension, hypercholesterolemia, and diabetes is linked to reduced regional aortic distensibility when compared with lean, age-and sexmatched control subjects. 8, 9 The pattern of this reduction shows a relatively greater reduction in distensibility in the more distal (abdominal) part the aorta as opposed to the more proximal portion (ascending aorta).
The reasons behind this distal pattern of change are not known but may be related to elevated free fatty acid, levels which are not only reported in obesity, 8 -12 but are also known to increase arterial stiffness in human and animal studies. Despite this combination of elevated free fatty acid levels and increased aortic stiffness, an association between circulating free fatty acids and aortic distensibility in obesity has not been established.
High free fatty acid (FFA) levels decrease endothelial nitric oxide synthase activity and impair endotheliumdependent vasodilation. 13, 14 In humans, endotheliumdependent vasodilation and nitric oxide production are impaired when free fatty acids are increased by an intralipidheparin infusion. 14 -16 In addition, elevated FFAs as a result of intralipid infusion has been shown to initiate a state of oxidative stress with increased reactive oxygen species production. 17 Although reactive oxygen species play a physiological role in the control of endothelial function and vascular tone, they also play a pathophysiological role in inflammation, hypertrophy, proliferation, apoptosis, and fibrosis, all important features of vascular remodelling and endothelial dysfunction. 18, 19 Although controversy still exists over their pathophysiological role, increased levels of reactive oxygen species and markers of oxidative stress are also a consistent feature of atherosclerosis and hypertension.
In view of this, we aimed to establish (1) if FFA levels were independently associated with increased regional aortic stiffness in obesity; (2) whether or not acute elevation of circulating plasma FFA levels with intravenous intralipid infusion reproduced the pattern of distensibility changes seen in obesity; and (3) if a similar change in aortic distensibility could be produced subacutely through dietary modulation of FFA levels.
To achieve this, we used regional vascular MRI to assess aortic distensibility in 35 normal-weight and 70 subjects with a body mass index (BMI) Ͼ25 kg/m 2 and correlated this to fasting serum FFA levels. Furthermore, we recorded aortic distensibility in 2 additional cohorts before and after elevating FFA levels through either an intralipid infusion (at 1 and 4 hours) or a 5-day low-carbohydrate, high-fat diet both known to elevate serum FFA levels.
Methods
All subjects were recruited from the Oxfordshire community on a voluntary basis by poster advertising. All applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. This study was approved by the Milton Keynes Local Research Ethics Committee and written informed consent was obtained for each subject. All subjects were screened for the presence of identifiable cardiovascular risk factors and excluded if the following were present: hypertension (140/90 mm Hg averaged over 3 supine values), hypercholesterolemia (Ͼ6.0 mmol/L), diabetes (fasting glucose Ͼ7.1 mmol/L), use of any prescription medication, an abnormal resting electrocardiogram, a history of obstructive sleep apnea, valvular heart disease, or aortic disease. All tests were performed fasting, although water was encouraged for adequate hydration.
A Comparison of Overweight and Obese With Normal-Weight Subjects
One hundred five subjects (70 overweight and obese subjects, 35 normal weight) were recruited into this arm of the study (BMI range, 18.7-59.2 kg/m 2 ). All subjects underwent vascular MRI and fasting blood tests.
Intralipid Infusion
A second group of normal-weight subjects (nϭ9) were recruited to this arm of the study basis by poster advertising. To acutely elevate FFAs, an infusion (20% Intralipid Fresenius Kabi) was given at 60 mL/hr for 4 hours. Unfractionated heparin (Monoparin; CP Pharmaceuticals) was infused at 0.4 U/kg/min to further increase triglyceride breakdown through activation of lipoprotein lipase. Vascular MRI and blood tests was performed at 0, 1 hour, and 4 hours as described subsequently.
Dietary Elevation
A third cohort (nϭ14) of healthy subjects was prescribed a 5-day high-fat and low-carbohydrate diet (based on the Atkins diet). 20 Vascular MR and blood tests were performed pre-and postdiet. All tests were performed at the same time each morning after an overnight fast. On the fat diet, 70% of daily caloric intake was prescribed as fat, 4% as carbohydrates (20 g per 2000 kcal), and 26% as protein. All subjects completed a prospective detailed food and beverage diary during the study. Post hoc analysis of dietary composition was performed with a computer-based program, Diet-plan6 professional version (Forestfield Software Ltd, West Sussex, UK). To ensure adequate micronutrient intake, subjects were given a daily multivitamin supplement.
Aortic Imaging
All MR scans for the assessment of cardiac output and aortic distensibility were performed on a 1.5-T MR system (Siemens Medical Solutions, Erlangen, Germany), as previously described. 21 Indices of aortic function were assessed using an steady-state free precession cine sequence with the following parameters: TR 42 ms, TE 1.4 ms, field of view read 380 mm, in-plane resolution 1.97 mm, and slice thickness 7 mm. Based on sagittal-oblique pilot images aligned with the aortic arch, aortic cine images were acquired in transverse planes at 3 levels: the crossing of the pulmonary arch through (1) the ascending thoracic aorta (Ao); (2) descending thoracic aorta (PDA); and (3) 12 cm below the Ao (DDA) as previously described (Figure 1 ). 22 The abdominal cine images were piloted perpendicular to the orientation of the abdominal aorta. During the acquisition of the images, a brachial blood pressure was recorded to provide the systolic and diastolic aortic pressures at the same time as the volume images were being acquired, as previously described. [22] [23] [24] 
Data Analysis
Aortic cross-sectional area in systole and diastole was calculated using an automated in-house software program within Matlab 6.5; aortic diameter was then calculated from this. Vascular distensibility was calculated as previously described and shows highly reproducible assessment of distensibility. 25 Aortic distensibility represents the relative change in area of the aorta per unit pressure, taken here as the pulse pressure and is calculated according to the formula: aortic distensibilityϭ(A max ϪA min )/A min /(P max ϪP min ), where A max ϭmaximal (systolic) area (mm 2 ), A min ϭminimal (diastolic) area (mm 2 ), P max ϭsystolic blood pressure (mm Hg), and P min ϭdiastolic blood pressure (mm Hg). The coefficient of variation of this automated method is 0.32% for intrastudy repeat analysis and 2.18% for interstudy repeated acquisition and analysis. 26 Aortic wall thickness measurements were calculated from an average of that recorded on T1 weighted anatomic images and steady-state free precession cine sequences.
Statistical Analysis
All statistical analysis was performed using SPSS statistical software (Version 15.0; SPSS Inc, Chicago, IL). Data are expressed as meansϮSD unless otherwise stated. All continuous variables were normally distributed as assessed by the Kolmogorov-Smirnov test. Differences between obese and normal groups were assessed by Student unpaired t test. Differences between pre-and postdiet were assessed with Student paired t test, a probability value of PϽ0.05 was considered significant, and 2-tailed probability values were used for all statistics. For analysis of the 3 time point infusion study, repeated-measures analysis of variance was performed with post hoc Bonferroni correction. Pearson correlation and multiple regression were used for analyses of associations among continuous variables. The associations among FFA levels, BMI, blood pressure, and aortic distensibility were analyzed initially without any adjustments (crude model) and then with adjustments for potential confounders (adjusted models). Because aortic distensibility structure is known to be affected by BMI, blood pressure, and age, these variables were considered in the adjusted models. For FFA levels, data are presented as absolute and log values. In addition, to investigate the differential effect of BMI on FFA-induced aortic distensibility (AD) decrease further, we have used dummy variable regression analysis to compare the coefficient of regression between FFA levels and abdominal aortic distensibility in normal-weight (BMI, 18.5-25 kg/m 2 ), overweight (BMI, 25-30 kg/m 2 ), obese (BMI, 30 -35 kg/m 2 ), and severely obese (BMI, Ͼ35 kg/m 2 ).
Blood Tests
For the infusion study, fasting blood tests for FFA levels, glucose, insulin, and cholesterol were taken at baseline and after 1 and 4 hours of intralipid infusion. In the diet arm of the study, fasting samples were taken on the first and last days of the study at the same time each morning. Samples were immediately centrifuged and the plasma supernatant frozen at Ϫ80°C with a final concentration of 30 g/mL lipoprotein lipase inhibitor (tetrahydrolipstatin, Xenical; Roche) for determination of FFAs. An average of 3 values for FFA levels was used for the analysis. 
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Results
Baseline Characteristics
One hundred five subjects were included (70 overweight/ obese and 35 normal weight) were included in this part of the study (BMI range normal, 18.7-24.9 kg/m 2 , overweight/ obese 25.0 -59.2 kg/m 2 ). Obese subjects were on average 16.1 kg/m 2 heavier than their lean counterparts. Despite this, the 2 groups were well matched for age, fasting glucose, fasting cholesterol, and diastolic blood pressure. (Table 1) .
Although systolic blood pressures was significantly higher in the obese subjects, numerically the difference was small and the measurements were well within the normal range for both groups ( Table 1 ). The baseline characteristics of the subjects in the infusion arm and the diet arm are shown in Table 2 .
FFA Levels and AD
Obesity
Obesity was associated with both a 58% increase in FFA levels (normal weight, 0.33Ϯ0.28 mmol/L versus obese, 0.52Ϯ0.28 mmol/L; PϽ0.001) and a reduction in AD at all 3 levels measured (by 22% in the ascending, 25% in the proximal descending aorta, and by 35% in the abdominal aorta; PϽ0.01 for all analyses). As previously reported, more distal (abdominal) sections were associated with greater reductions in distensibility as opposed to more proximal sections ( Figure 1A ).
AD and Obesity (Crude and Adjusted Associations)
To assess the associations of regional AD in obesity, Pearson correlation across all subjects was performed (nϭ105). In agreement with previously published data, AD, at all 3 levels measured, was statistically correlated with age, BMI, and systolic blood pressure (Table 3 ). In addition, AD at all 3 levels measured was negatively correlated with serum FFA levels, a novel observation. Furthermore, the strongest correlation between both FFA levels and log10 FFA levels and AS occurred in the abdominal aorta (rϭϪ0.65 and rϭϪ0.59 respectively; PϽ0.001; Table 3 ; Figure 2 ). Interestingly, the relationship between FFA and AD is marginally stronger when modeled as an exponential decay rather than a linear relationship (exponential rϭ0.67, PϽ0.001, linear rϭ0.65, PϽ0.001; Figure 2 ); this might be expected because at the extremes of AD, FFA change would not be likely to continue to have a linear effect on AD. In addition, abdominal distensibility was negatively correlated with serum leptin, C-reactive protein, and fasting glucose level, all of which when elevated are hallmarks of obesity (Table 3) . When adjusted for aortic wall thickness, there was no significant change in the relationship between FFA and abdominal AD (rϭ0.64, PϽ0.001).
Because age, systolic blood pressure, and BMI were all statistically correlated with AD, an adjusted model accounting for these effects was used. This revealed, when controlling for the effects of age, blood pressure, and BMI, that FFA levels remained negatively correlated with AD at the level of the abdominal aorta (rϭϪ0.52, PϽ0.001). In contrast, however, the association between ascending and proximal descending AD and FFA levels became nonsignificant when adjusting for age, BMI, and systolic blood pressure (rϭϪ0.13, Pϭ0.27 and rϭϪ0.15, Pϭ0.13, respectively). Similar results were attained using log10 FFA levels (data not shown).
Using dummy variable regression analysis to compare the coefficient of regression between FFA levels and abdominal AD in normal-weight (BMI, 18.5-25 kg/m 2 ), overweight (BMI, 25-30 kg/m 2 ), obese (BMI, 30 -35 kg/m 2 ), and severely obese (BMI, Ͼ35 kg/m 2 ), this showed that there was no statistically significant difference in the slope of regression between FFA and AD across the BMI groups (Figure 3 ). However, given the 
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Intralipid Infusion
After 1 Hour of Infusion
As expected, plasma FFA levels were significantly elevated after 1 hour of the intralipid infusion (baseline 0.27Ϯ0.14 mmol/L versus 1 hour 1.10Ϯ0.81 mmol/L; PϽ0.01; Figure 1 ). Glucose and insulin levels were unchanged after 1 hour of infusion (glucose pre 4.1Ϯ0.8 versus 1 hour 4.1Ϯ0.8, Pϭ0.12, insulin pre 5.7Ϯ2.6 versus 5.8Ϯ2.1, Pϭ0.73). There were no differences in aortic elastic function after 1 hour of the intralipid infusion at any level of the aorta ( Figure 1B) .
After 4 Hours of Infusion
As expected, plasma FFA levels were significantly elevated after 1 and 4 hours of the intralipid infusion (baseline 0.27Ϯ0.14 mmol/L, 4 hours 1.69Ϯ0.58 mmol/L, PϽ0.004; Figure 1 ). In agreement with published data, both systolic (SBP) and diastolic blood pressure were elevated during the intralipid infusion (SBP pre 119Ϯ10 mm Hg versus during 131Ϯ12 mm Hg, diastolic blood pressure pre 75Ϯ8 versus 80Ϯ8 mm Hg; both PϽ0.05). In addition, pulse pressure was also higher after 4 hours of intralipid infusion (45Ϯ8 versus 51Ϯ8 mm Hg, Pϭ0.014 However, in contrast to the results after 1 hour of infusion, after 5 hours of intralipid infusion, there was a 22% decrease in abdominal AD when compared with baseline (DDA 8.56Ϯ1.7 versus 11.00Ϯ2.3 mm Hg Ϫ1 ϫ10 Ϫ3 ; Pϭ0.03; Figure 1 ). In contrast to this, there was no significant decrease in AD in the ascending or proximal descending aorta (Figure 1 ). This pattern of distensibility change is similar to that seen in obesity.
It is well established that intralipid infusion and the resultant elevation in FFA cause insulin resistance, and this study again reports an elevated Homeostasis Model Assessment after 4 hours of intralipid infusion. It might be expected that insulin resistance would be related to AD given the evidence that insulin resistance has been linked to endothelial dysfunction by a number of mechanisms, including disturbances of subcellular signaling pathways common to both insulin action and nitric oxide production. 27 However, in this small study, no relationship was found between the change in Homeostasis Model Assessment and the change in distensibility during intralipid infusion. Interestingly, aortic wall thickness in the abdominal aorta at baseline was strongly, negatively correlated with the reduction in abdominal AD during intralipid infusion (rϭϪ0.77, Pϭ0.02; Table 4 ).
To assess whether the reduction in AD observed is likely due to a reduction in the elasticity of the aortic, rather than the increased pulse pressure, systolic and diastolic aortic-crosssectional areas were measured before and after the infusion. After 4 hours of intalipid infusion, diastolic aortic area was similar in the ascending and proximal descending aorta (Ao 404Ϯ79 versus 421Ϯ68 mm 2 , Pϭ0.20; PDA 266Ϯ47 versus 278Ϯ55 mm 2 , Pϭ0.21). In contrast, there was a small but significant increase in diastolic aortic area in the abdominal aorta (DDA by 6%, 171Ϯ24 versus 181Ϯ24 mm 2 , Pϭ0.03). Interesting, despite the observed increase in pulse pressure during the intralipid infusion, systolic aortic areas remained similar at all 3 levels (Ao 551Ϯ98 versus 581Ϯ81 mm 2 , Pϭ0.12; PDA 348Ϯ48 versus 366Ϯ69 mm 2 , Pϭ0.17; DDA, 253Ϯ36 versus 258Ϯ31 mm 2 , Pϭ0.57). In addition, absolute change in aortic area with systole, before and after the infusion, was similar for all levels recorded (Ao 147Ϯ43 mm 2 versus post 160Ϯ39 mm 2 , Pϭ0.30; PDA pre 82Ϯ21 mm 2 versus post 78Ϯ11 mm 2 , Pϭ0.53; DDA pre 88Ϯ21 mm 2 versus post 82Ϯ15 mm 2 , Pϭ0.13). Taken together, this would suggest that the reduction in AD during intralipid infusion is likely due to a reduction in aortic wall elasticity, not to changes in pulse pressure.
Low-Carbohydrate, High-Fat Diet
After 5 days of a high-fat and low-carbohydrate diet, which contained 75%Ϯ1% of caloric intake through fat and 4%Ϯ1% through carbohydrates, plasma FFA levels increased by 48% (pre 0.33Ϯ0.14 versus post 0.49Ϯ0.21 mmol/L, Pϭ0.02) and subjects were significantly lighter (BMI 25.7Ϯ2.0 pre versus 25.0Ϯ1.9 kg/m 2 post, PϽ0.001). Fasting serum glucose was statistically lower after the dietary period (4.9Ϯ0.41 versus 4.3Ϯ0.52 mmol/L, Pϭ0.02), whereas cholesterol level remained unchanged (5.3Ϯ1.0 versus 5.5Ϯ1.0 mmol/L, Pϭ0.37). Both SBP and diastolic blood pressure remained similar pre and post the 5-day dietary period (SBP pre 117Ϯ8 mm Hg versus post 117Ϯ10 mm Hg, Pϭ0.43 DPB pre 77Ϯ9 mm Hg versus post 77Ϯ8 mm Hg Pϭ0.17). Of note, unlike the intralipid infusion study, pulse pressure was similar before and after the 5 day diet (pre 41Ϯ6 mm Hg versus post 42Ϯ9 mm Hg Pϭ0.34).
After the dietary period, there was a significant 28% decrease in AD measured at the level of the abdominal aorta (DDA 7.4Ϯ2.4 versus 5.3Ϯ2.3 mm Hg Ϫ1 ϫ10 Ϫ3 ; PϽ0.02). Again, there were no significant changes in more proximal sections (Figure 1 ). Because pulse pressure remained similar before and after the dietary period, we assessed systolic and diastolic cross-sectional areas to determine whether intrinsic elasticity of the aorta had changed. As a group, after the low-fat diet, there was no difference in diastolic aortic area (Ao 540Ϯ131 versus 549Ϯ154 mm 2 , Pϭ0.57; PDA 299Ϯ74 versus 304Ϯ77 mm 2 , Pϭ0.59; DDA, 233Ϯ47 versus 237Ϯ43 mm 2 , Pϭ0.40) or 
Discussion
In this study, obesity, in the absence of additional identifiable cardiac risk factors, was associated with reduced AD in a predominantly distal distribution and with elevated FFA levels, consistent with previous studies of obesity and aortic elastic function. 9, 28 In addition to this, we have shown not only that circulating FFA levels are negatively correlated with regional AD, but also that the relationship between FFA levels and distensibility is stronger in more distal aortic regions and is not affected by aortic wall thickness. Furthermore, the strong negative correlation between FFA levels and abdominal distensibility was independent of the effects of age, SBP, and BMI. In addition, we have shown that both acute elevation of FFA levels with intralipid infusion and dietary elevation with a lowcarbohydrate diet also reproduce this pattern of AD change.
These findings demonstrate elevated FFAs as a mechanism that is likely to contribute to the reduction in AD in obesity.
The Effect of Obesity on AD
Because obesity is associated with increased arterial stiffness, [3] [4] [5] an independent predictor of mortality, 7 this has become 1 of the candidate mechanisms to explain at least part of the increased mortality seen in obesity. This study again confirms increased aortic stiffness in obesity but, in addition, has shown that elevated FFA levels may be responsible for the predominantly distal pattern of reduced AD change seen in obesity with FFA levels being an independent predictor of abdominal AD. Elevated visceral fat mass is a plausible explanation for this finding. Visceral obesity has been linked to both elevated reactive oxygen species and increased fatty acid levels, both of which have been shown to impair endothelium-derived relaxation. 29 Because elevation of FFA levels has been shown to produce a blunted blood flow response to endotheliumdependent relaxation in human and animal models and has been associated with oxidative stress, 13, 29 it is likely that increased visceral fat mass and elevated serum FFA levels seen here in obesity are contributing significantly to aortic stiffness. Fatty acid-driven activation of protein kinase C-dependent production of reactive oxygen species is thought to increase oxidative stress, 30 which has been linked to hypertension and vascular remodeling and is a plausible mechanism to explain the changes seen in this study. 13, 31 However, although it might be expected that the slope of the relationship between FFA and AD would be different in the obese group when compared with the normalweight group, there was no difference in the coefficient of regression of the relationship between FFA and AD when comparing normal-weight with overweight or obese subjects.
This would again suggest that it is the level of serum FFA that is determining AD, not the underlying BMI.
The Effect of Acute Elevation of Fatty Acid Levels on AD
To investigate this, intravenous intralipid infusion was used to artificially elevate serum FFAs over a period of 4 hours. During infusion, accompanying the large elevation in FFA level was a decrease in AD. Interestingly, the pattern of distensibility change during infusion mimics that seen in obesity with more distal aortic regions showing a reduction in distensibility. Because pulse pressure was elevated during the intralipid infusion, it would be expected that the difference between aortic cross-sectional area in systole and diastole would increase, consistent with the increase in aortic distending pressure. However, this was not observed, suggesting that the change in distensibility was due to an intrinsic decrease in aortic wall elasticity in the proximal descending and abdominal aorta but not in the ascending aorta where distensibility was unchanged. The elevation of FFA levels during the infusion in combination with the decrease in distensibility would suggest a negative effect of FFAs on AD. Given the fact that the pattern is predominantly distal, as seen in obesity, this raises the likelihood that, in obesity, elevated FFA levels are at least in part responsible for the distal pattern of distensibility changes seen. Interestingly, baseline abdominal aortic wall thickness, a surrogate marker of subclinical atherosclerosis, was negatively correlated with the decrease in distensibility during FFA elevation, suggesting that the thicker aortic wall is less reactive to acute elevations in FFA.
Oxidative stress provides a potential mechanism behind the effects of elevated FFA on aortic function. Reactive oxygen species, either by increased production (through mitochondrial electron transport chain, reduced nicotinamide-adenine dinucleotide phosphate oxidase, xanthine oxidase, or uncoupled nitric oxide synthase) or decreased removal (through superoxide dismutase or catalase), are thought have a negative impact on vascular function. Intralipid-heparin infusioninduced elevated FFA levels are known to decrease endothelium-dependent vasodilation, nitric oxide production, 14 -16 decrease endothelial nitric oxide synthase activity, and impair endothelium-dependent vasodilation. 15, 16 It is well established that intralipid infusion and the resultant elevation in FFA cause insulin resistance, and this study again reports an elevated Homeostasis Model Assessment after 4 hours of intralipid infusion. It might be expected that insulin resistance would be related to AD given the evidence that insulin resistance has been linked to endothelial dysfunction by a number of mechanisms, including disturbances of subcellular signaling pathways common to both insulin action and nitric oxide production. 27 However, in this small study, no relationship was found between the change in Homeostasis Model Assessment and the change in distensibility during intralipid infusion. Despite this, intralipid infusion in healthy normal-weight subjects raised plasma fatty acids, increased SBP, and reduced large artery elastic function, a similar finding as that seen in insulin resistance in obesity. However, given this is a small proof-of-principle study, further investigation on a larger population is needed.
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However, plasma levels of FFAs recorded during the intralipid infusion were supraphysiological and on average Ͼ50% greater than the highest level recorded in our experience in obese subjects. In addition to this, intralipid infusion was seen to elevate pulse pressure, a major determinant of distensibility. As a result, it must be noted that acute supraphysiological levels of FFAs may, in combination the absolute increase in pulse pressure, have a different or greater inhibitory action than that seen at physiologically elevated levels. In view of this, FFAs were in the third part of this study elevated using a low-carbohydrate, high-fat diet in normal-weight healthy subjects. This increased fatty acids over a longer period of time (5 days) to physiological levels seen in obesity and avoided the changes in pulse pressure.
The Effect of Dietary Elevation of FFA Levels on AD
Again, in this study, associated with an increase in FFA levels that occurred with dietary modification was a predominantly distal pattern of increased aortic stiffness again similar to that seen in obesity. Notably, like the changes seen in the infusion study, this decrease in distensibility occurred without change in SBP or pulse pressure. Interestingly, despite a significant decrease in BMI, which has been proved in the setting of obesity to increase AD and decrease FFA levels, 6 weight loss in this study was associated with an increase in FFA levels and decreased AD, the opposite of previous findings of weight loss on a low-calorie diet. 6 This further points toward the deleterious effect of elevated FFAs on vascular function. However, given the fact that dietary increases in FFA were performed in a population free of cardiovascular risk factors, it remains to be seen whether the effects of dietary modulation of FFA remain in a population who already have risk factors associated with vascular elastic dysfunction (eg, hypertension, diabetes).
The Pattern of AD
The structural heterogeneity of the aorta is a possible explanation for the predominantly distal pattern of change reported in this study. The aorta is a structurally and physiologically heterogeneous vessel with decreasing elastin:collagen ratios along its length (ratios of 3.1:1 at the ascending aorta and arch compared with 2.8:1 at the midthoracic region and 0.8:1 at the abdominal region). 32 Regions with higher proportions of elastin have higher elasticity. In the ascending aorta, this is essential for its function as a "Windkessel" attenuating the pulse wave arising from left ventricular systolic contraction. It follows then that physiologically less elastic parts of the aorta would be affected first by a pathological process that decreases elastic mechanical function, in this case elevations in FFA levels.
Limitations
Distensibility was calculated using pulse pressure measurements taken from brachial blood pressure rather than central blood pressure recordings. Although we accept central pressure recording may have changed the absolute aortic distensibility measures, given the magnitude of the changes recorded during the infusion in the abdominal segment (ie, Ͼ25% change in distensibility), the pattern of change, that is, the main finding of this article, would not be expected to be affected.
No separate heparin infusion was performed in the infusion study. Because heparin has small but definite detrimental effects on vascular function, this is an important consideration. However, because the diet arm showed similar changes with FFA increases in the absence of heparin, this adds weight to the evidence for an effect of FFA alone on arterial function.
This study has been performed in a small population of well subjects who are free of cardiovascular risk factors. Because the majority of cardiovascular events occur in an older population with risk factors, extrapolating the results this population needs caution. As such, these data serve as a small proof-of-principle study that needs further investigation.
Measurements of insulin resistance in this study were calculated using the Homeostasis Model Assessment model. This technique is defined as a fasting measurement and during intralipid infusion, subjects are no longer in the fasting steady state making this assessment more difficult to interpret. However, the increase in insulin during intralipid infusion without a concomitant increase in glucose (which might theoretically increase due to glycerol load and gluconeogenesis) would suggest that insulin resistance is the mechanism underlying the increase in Homeostasis Model Assessment seen here in this study.
Conclusion
Obesity is related to increased fatty acid levels and decreased AD in a pattern that predominantly affects the abdominal aorta. This raises the question as to whether elevated FFA levels cause reduced distensibility. In this study, when controlling for age, blood pressure, and SBP, FFA levels remained correlated with abdominal AD. In addition to this, during both acute elevation of FFA levels through intralipid infusion and a low-carbohydrate, high-fat diet, abdominal AD decreased. This predominantly distal pattern of decrease is similar to that seen in obesity. These findings not only add weight to the theory that obesity acts to produce increased aortic stiffness through elevated FFA levels, but also have potentially further reaching clinical implications, for example, in the coronary circulation, where the effects of elevated FFA are unknown but may well be important in the development of coronary artery atherosclerosis. 
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CLINICAL PERSPECTIVE
Obesity is associated with increased mortality and is now a well-recognized risk factor for cardiovascular disease, exerting independent adverse effects on the cardiovascular system. Because obesity is associated with increased arterial stiffness, an independent predictor of mortality, this has become 1 of the candidate mechanisms to explain at least part of the increased mortality seen in obesity. Despite the well-documented link between obesity and vascular stiffness, the mechanisms by which obesity modulates vascular function are not well understood. Insulin-resistant states such as obesity are characterized by elevated plasma free fatty acid levels, which have been shown to be associated with a greater risk of developing impaired glucose tolerance and Type 2 diabetes. In this study, we not only demonstrate a relationship between aortic distensibility and free fatty acid in obesity, but also that acute elevation of free fatty acid in normal-weight individuals free of cardiovascular disease induces insulin resistance and reduces aortic distensibility within 4 hours in a pattern similar to that seen in obesity. Furthermore, we have shown that dietary elevation of free fatty acid also reduces aortic distensibility, again in a similar pattern to obesity. These findings demonstrate elevated free fatty acids as a mechanism that is likely to contribute to the reduction in aortic distensibility in obesity and open the possibility of elevated free fatty acid as a potential therapeutic target to improve vascular function in obesity, which, given its relationship with cardiovascular mortality, has wide-reaching clinical implications.
